Masanori Horinouchi

MDR1 Genotype-Related Pharmacokinetics of Digoxin After Single Oral Administration in Healthy Japanese Subjects

Toshiyuki Sakaeda, Tsutomu Nakamura, Masanori Horinouchi et al. · Pharmaceutical Research · 2001 · 321 citations

Medicine, Pharmacokinetics, Pharmacology +6

Effect of the mutation (C3435T) at exon 26 of the <i>MDR1</i> gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects

Tsutomu Nakamura, Toshiyuki Sakaeda, Masanori Horinouchi et al. · Clinical Pharmacology & Therapeutics · 2002 · 260 citations

Life Sciences, Genetics, Molecular Biology +12

Effects of Polymorphisms of MDR1, MRP1, and MRP2 Genes on Their mRNA Expression Levels in Duodenal Enterocytes of Healthy Japanese Subjects.

Yuka Moriya, Tsutomu Nakamura, Masanori Horinouchi et al. · Biological and Pharmaceutical Bulletin · 2002 · 128 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Significant Genetic Linkage of MDR1 Polymorphisms at Positions 3435 and 2677: Functional Relevance to Pharmacokinetics of Digoxin

Masanori Horinouchi, Toshiyuki Sakaeda, Tsutomu Nakamura et al. · Pharmaceutical Research · 2002 · 127 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +10

Cytotoxic Effects of 27 Anticancer Drugs in HeLa and MDR1-Overexpressing Derivative Cell Lines.

Kohji Takara, Toshiyuki Sakaeda, Tatsurou Yagami et al. · Biological and Pharmaceutical Bulletin · 2002 · 97 citations · Full text

Medicine, Oncology, Pharmacology +15